Cornerstone Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,261
Closed -$1.96M 226
2024
Q2
$1.96M Buy
6,261
+8
+0.1% +$2.35K 0.1% 38
2024
Q1
$1.78M Buy
6,253
+8
+0.1% +$2.34K 0.09% 45
2023
Q4
$1.8M Buy
6,245
+7
+0.1% +$1.91K 0.1% 43
2023
Q3
$1.68M Buy
6,238
+23
+0.4% +$5.74K 0.1% 41
2023
Q2
$1.38M Hold
6,215
0.08% 46
2023
Q1
$1.5M Buy
6,215
+705
+13% +$173K 0.1% 42
2022
Q4
$1.45M Hold
5,510
0.09% 42
2022
Q3
$1.24M Buy
+5,510
New +$1.34M 0.09% 43
2016
Q3
Sell
-2,428
Closed -$369K 81
2016
Q2
$369K Buy
+2,428
New +$377K 0.01% 73

Other funds holding AMGN

Cornerstone Investment Partners's AMGN Position: Q3 2024 in Review

Cornerstone Investment Partners sold out of Amgen (AMGN) in Q3 2024, closing a stake of 6,261 shares — an estimated $1.96M sold.

Cornerstone Investment Partners first reported a position in AMGN in Q2 2016 and held it in 9 quarters. The position peaked at $1.96M in Q2 2024. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Cornerstone Investment Partners reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Cornerstone Investment Partners sold 6,261 Amgen shares in Q3 2024, an estimated $1.96M.
  • Cornerstone Investment Partners first reported a position in Amgen in Q2 2016 and held it in 9 quarters.
  • Cornerstone Investment Partners's Amgen position peaked at $1.96M in Q2 2024.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Cornerstone Investment Partners's 13F filing for Q3 2024, filed 13 Nov 2024.